Comparative Pharmacology
Head-to-head clinical analysis: SULFACETAMIDE SODIUM versus SULLA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SULFACETAMIDE SODIUM versus SULLA.
SULFACETAMIDE SODIUM vs SULLA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitively inhibits dihydropteroate synthase, blocking folic acid synthesis in susceptible bacteria.
SULLA (sulfamethoxazole/trimethoprim) inhibits bacterial dihydropteroate synthase and dihydrofolate reductase, sequentially blocking folate synthesis and thereby nucleic acid production.
1-2 drops of 10-30% solution into the conjunctival sac every 2-3 hours initially, tapering as infection resolves. Ointment: 0.5-inch ribbon into conjunctival sac every 3-4 hours and at bedtime.
100 mg orally once daily, increased to 200 mg daily if needed.
None Documented
None Documented
7-12.8 hours (prolonged in renal impairment; requires dosing adjustment in CrCl <50 mL/min).
6-12 hours; prolonged in renal impairment (up to 30 hours)
Renal: 85-95% unchanged via glomerular filtration and tubular secretion. Biliary/fecal: <5%.
Renal: 70-90% unchanged; biliary/fecal: 5-10%
Category A/B
Category C
Sulfonamide Antibiotic
Sulfonamide Antibiotic